April 16, 2018 - By Michael Lund

Cannabics Pharmaceuticals Inc. (OTCMKTS:CNBX) Corporate Logo

Change of 2.56% for CANNABICS PHARMACEUTICALS INC (OTCMKTS:CNBX)’s shares shorted was recorded. FINRA announced in April CNBX’s total 276,800 shares shorted. Previously was reported up change of 2.56% from 269,900 shares. Former CNBX’s position will need 0 days to recover. It has 936,600 average volume. 0.89% is CANNABICS PHARMACEUTICALS INC float short.

Its shares touched $1.18 on during the last trading session after 6.31% change.Cannabics Pharmaceuticals Inc. has volume of 421,928 shares. Since April 16, 2017 CNBX has 0.00% and is . The stock underperformed the S&P 500 by 11.55%.

Cannabics Pharmaceuticals Inc. engages in the research, development, licensing, and marketing of cannabinoid treatments and therapies.The firm is worth $142.17 million. The firm focuses on developing therapies and biotechnological tools for the relief from various ailments that respond to active ingredients sourced from the cannabis plant.Last it reported negative earnings. The Company’s flagship product is Cannabics SR, a long acting medical cannabis capsule that shows therapeutic effects as a palliative care therapy for cancer patients.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.